Abstract
Interleukin-19 (IL-19), a pro-inflammatory cytokine known to stimulate the production of T helper type 2 (Th2) cytokines, is induced by IL-17A and highly expressed in the lesional skin of psoriasis and atopic dermatitis (AD). This aim of this study was to investigate whether IL-19 is involved in cutaneous T-cell lymphoma (CTCL) and AD. IL-19 levels were significantly higher in the sera of patients with AD and those with advanced-stage CTCL than in normal controls, correlating significantly with clinical disease markers. IL- 19 mRNA levels in lesional skin of both diseases were significantly elevated. Immunohistochemical staining revealed that IL-19 was expressed in the epidermis of AD skin and CTCL skin. In vitro, IL-17A and IL-4 increased IL-19 mRNA expression in human keratinocytes. Thus, IL-19 was increased in the sera and skin of AD and CTCL. These results suggest that IL-19 is important for bridging Th17 to Th2 in these diseases.
Original language | English |
---|---|
Pages (from-to) | 1172-1177 |
Number of pages | 6 |
Journal | Acta Dermato-Venereologica |
Volume | 97 |
Issue number | 10 |
DOIs | |
Publication status | Published - 2017 Nov |
Externally published | Yes |
Keywords
- Atopic dermatitis
- Cutaneous T-cell lymphoma
- IL-17A
- IL-19
- IL-4
- Keratinocytes
ASJC Scopus subject areas
- Dermatology